![Logo of OpenAlex.org Project OpenAlex Citations Logo](https://www.oahelper.org/wp-content/plugins/oahelper-citations/img/logo-openalex.jpg)
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Liquid Biopsy-Based Biomarkers of Treatment Response and Resistance
Elaine Kilgour, Dominic G. Rothwell, Ged Brady, et al.
Cancer Cell (2020) Vol. 37, Iss. 4, pp. 485-495
Open Access | Times Cited: 275
Elaine Kilgour, Dominic G. Rothwell, Ged Brady, et al.
Cancer Cell (2020) Vol. 37, Iss. 4, pp. 485-495
Open Access | Times Cited: 275
Showing 1-25 of 275 citing articles:
Liquid biopsy enters the clinic — implementation issues and future challenges
Michail Ignatiadis, George W. Sledge, Stefanie S. Jeffrey
Nature Reviews Clinical Oncology (2021) Vol. 18, Iss. 5, pp. 297-312
Closed Access | Times Cited: 822
Michail Ignatiadis, George W. Sledge, Stefanie S. Jeffrey
Nature Reviews Clinical Oncology (2021) Vol. 18, Iss. 5, pp. 297-312
Closed Access | Times Cited: 822
Molecular Biomarkers in Cancer
Virinder Kaur Sarhadi, Gemma Armengol
Biomolecules (2022) Vol. 12, Iss. 8, pp. 1021-1021
Open Access | Times Cited: 240
Virinder Kaur Sarhadi, Gemma Armengol
Biomolecules (2022) Vol. 12, Iss. 8, pp. 1021-1021
Open Access | Times Cited: 240
Therapy resistance: opportunities created by adaptive responses to targeted therapies in cancer
Marilyne Labrie, Joan S. Brugge, Gordon B. Mills, et al.
Nature reviews. Cancer (2022) Vol. 22, Iss. 6, pp. 323-339
Open Access | Times Cited: 199
Marilyne Labrie, Joan S. Brugge, Gordon B. Mills, et al.
Nature reviews. Cancer (2022) Vol. 22, Iss. 6, pp. 323-339
Open Access | Times Cited: 199
Liquid biopsy at the frontier of detection, prognosis and progression monitoring in colorectal cancer
Hui Zhou, Liyong Zhu, Jun Song, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 142
Hui Zhou, Liyong Zhu, Jun Song, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 142
Clinical application and detection techniques of liquid biopsy in gastric cancer
Shuo Ma, Meiling Zhou, Yanhua Xu, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 80
Shuo Ma, Meiling Zhou, Yanhua Xu, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 80
An Exosome-based Transcriptomic Signature for Noninvasive, Early Detection of Patients With Pancreatic Ductal Adenocarcinoma: A Multicenter Cohort Study
Kota Nakamura, Zhongxu Zhu, Roy S, et al.
Gastroenterology (2022) Vol. 163, Iss. 5, pp. 1252-1266.e2
Open Access | Times Cited: 77
Kota Nakamura, Zhongxu Zhu, Roy S, et al.
Gastroenterology (2022) Vol. 163, Iss. 5, pp. 1252-1266.e2
Open Access | Times Cited: 77
Integrating circulating-free DNA (cfDNA) analysis into clinical practice: opportunities and challenges
Miguel García-Pardo, Maisam Makarem, Janice J.N. Li, et al.
British Journal of Cancer (2022) Vol. 127, Iss. 4, pp. 592-602
Open Access | Times Cited: 72
Miguel García-Pardo, Maisam Makarem, Janice J.N. Li, et al.
British Journal of Cancer (2022) Vol. 127, Iss. 4, pp. 592-602
Open Access | Times Cited: 72
Circulating Tumor Cells for the Staging of Patients With Newly Diagnosed Transplant-Eligible Multiple Myeloma
Juan‐José Garcés, María‐Teresa Cedena, Noemí Puig, et al.
Journal of Clinical Oncology (2022) Vol. 40, Iss. 27, pp. 3151-3161
Open Access | Times Cited: 65
Juan‐José Garcés, María‐Teresa Cedena, Noemí Puig, et al.
Journal of Clinical Oncology (2022) Vol. 40, Iss. 27, pp. 3151-3161
Open Access | Times Cited: 65
Recent advances of small extracellular vesicle biomarkers in breast cancer diagnosis and prognosis
Yujin Lee, Jie Ni, Julia Beretov, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 64
Yujin Lee, Jie Ni, Julia Beretov, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 64
Diagnostic value of liquid biopsy in the era of precision medicine: 10 years of clinical evidence in cancer
Vincenza Caputo, Fortunato Ciardiello, Carminia M. Della Corte, et al.
Exploration of Targeted Anti-tumor Therapy (2023), pp. 102-138
Open Access | Times Cited: 36
Vincenza Caputo, Fortunato Ciardiello, Carminia M. Della Corte, et al.
Exploration of Targeted Anti-tumor Therapy (2023), pp. 102-138
Open Access | Times Cited: 36
Tumor- and circulating-free DNA methylation identifies clinically relevant small cell lung cancer subtypes
Simon Heeke, Carl M. Gay, Marcos R. Estecio, et al.
Cancer Cell (2024) Vol. 42, Iss. 2, pp. 225-237.e5
Open Access | Times Cited: 31
Simon Heeke, Carl M. Gay, Marcos R. Estecio, et al.
Cancer Cell (2024) Vol. 42, Iss. 2, pp. 225-237.e5
Open Access | Times Cited: 31
Circulating extracellular vesicles are effective biomarkers for predicting response to cancer therapy
Enping Zhou, Yumei Li, Feng Wu, et al.
EBioMedicine (2021) Vol. 67, pp. 103365-103365
Open Access | Times Cited: 82
Enping Zhou, Yumei Li, Feng Wu, et al.
EBioMedicine (2021) Vol. 67, pp. 103365-103365
Open Access | Times Cited: 82
PINK1 drives production of mtDNA-containing extracellular vesicles to promote invasiveness
Nicolas Rabas, Sarah E. Palmer, Louise Mitchell, et al.
The Journal of Cell Biology (2021) Vol. 220, Iss. 12
Open Access | Times Cited: 81
Nicolas Rabas, Sarah E. Palmer, Louise Mitchell, et al.
The Journal of Cell Biology (2021) Vol. 220, Iss. 12
Open Access | Times Cited: 81
Tissue-specific cell-free DNA degradation quantifies circulating tumor DNA burden
Guanhua Zhu, Yu Amanda Guo, Danliang Ho, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 68
Guanhua Zhu, Yu Amanda Guo, Danliang Ho, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 68
Liquid Biopsy: A Family of Possible Diagnostic Tools
Michela Battistelli
Diagnostics (2021) Vol. 11, Iss. 8, pp. 1391-1391
Open Access | Times Cited: 63
Michela Battistelli
Diagnostics (2021) Vol. 11, Iss. 8, pp. 1391-1391
Open Access | Times Cited: 63
Emerging digital PCR technology in precision medicine
Lexiang Zhang, Rokshana Parvin, Qihui Fan, et al.
Biosensors and Bioelectronics (2022) Vol. 211, pp. 114344-114344
Closed Access | Times Cited: 60
Lexiang Zhang, Rokshana Parvin, Qihui Fan, et al.
Biosensors and Bioelectronics (2022) Vol. 211, pp. 114344-114344
Closed Access | Times Cited: 60
Liquid biopsy in gastric cancer: predictive and prognostic biomarkers
Zihao Zhang, Hao Wu, Wei Chong, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 10
Open Access | Times Cited: 60
Zihao Zhang, Hao Wu, Wei Chong, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 10
Open Access | Times Cited: 60
Prognostic Significance of Gene Expression and DNA Methylation Markers in Circulating Tumor Cells and Paired Plasma Derived Exosomes in Metastatic Castration Resistant Prostate Cancer
Martha Zavridou, Αreti Strati, Evangelos Bournakis, et al.
Cancers (2021) Vol. 13, Iss. 4, pp. 780-780
Open Access | Times Cited: 57
Martha Zavridou, Αreti Strati, Evangelos Bournakis, et al.
Cancers (2021) Vol. 13, Iss. 4, pp. 780-780
Open Access | Times Cited: 57
CRISPR-Cas13 System as a Promising and Versatile Tool for Cancer Diagnosis, Therapy, and Research
Fahreddin Palaz, Ali Kerem Kalkan, Özgür Can, et al.
ACS Synthetic Biology (2021) Vol. 10, Iss. 6, pp. 1245-1267
Closed Access | Times Cited: 55
Fahreddin Palaz, Ali Kerem Kalkan, Özgür Can, et al.
ACS Synthetic Biology (2021) Vol. 10, Iss. 6, pp. 1245-1267
Closed Access | Times Cited: 55
Emerging SERS biosensors for the analysis of cells and extracellular vesicles
Mohammad Tavakkoli Yaraki, Anastasiia Tukova, Yuling Wang
Nanoscale (2022) Vol. 14, Iss. 41, pp. 15242-15268
Closed Access | Times Cited: 50
Mohammad Tavakkoli Yaraki, Anastasiia Tukova, Yuling Wang
Nanoscale (2022) Vol. 14, Iss. 41, pp. 15242-15268
Closed Access | Times Cited: 50
Methylation biomarkers for early cancer detection and diagnosis: Current and future perspectives
Joe Ibrahim, Marc Peeters, Guy Van Camp, et al.
European Journal of Cancer (2022) Vol. 178, pp. 91-113
Closed Access | Times Cited: 44
Joe Ibrahim, Marc Peeters, Guy Van Camp, et al.
European Journal of Cancer (2022) Vol. 178, pp. 91-113
Closed Access | Times Cited: 44
Recent progress of nanozymes with different spatial dimensions for bioanalysis
Mengying An, Mengqi He, Caishi Lin, et al.
Materials Today Nano (2023) Vol. 22, pp. 100330-100330
Closed Access | Times Cited: 29
Mengying An, Mengqi He, Caishi Lin, et al.
Materials Today Nano (2023) Vol. 22, pp. 100330-100330
Closed Access | Times Cited: 29
A Liquid Biopsy Signature for the Early Detection of Gastric Cancer in Patients
Xin Guo, Yunhua Peng, Qiying Song, et al.
Gastroenterology (2023) Vol. 165, Iss. 2, pp. 402-413.e13
Closed Access | Times Cited: 27
Xin Guo, Yunhua Peng, Qiying Song, et al.
Gastroenterology (2023) Vol. 165, Iss. 2, pp. 402-413.e13
Closed Access | Times Cited: 27
Recommendations for Cell-Free DNA Assay Validations
Christina M. Lockwood, Laetitia Borsu, Milena Cankovic, et al.
Journal of Molecular Diagnostics (2023) Vol. 25, Iss. 12, pp. 876-897
Open Access | Times Cited: 25
Christina M. Lockwood, Laetitia Borsu, Milena Cankovic, et al.
Journal of Molecular Diagnostics (2023) Vol. 25, Iss. 12, pp. 876-897
Open Access | Times Cited: 25
Precision cancer medicine: Concepts, current practice, and future developments
Anders Edsjö, Louise Holmquist, Birgit Geoerger, et al.
Journal of Internal Medicine (2023) Vol. 294, Iss. 4, pp. 455-481
Open Access | Times Cited: 20
Anders Edsjö, Louise Holmquist, Birgit Geoerger, et al.
Journal of Internal Medicine (2023) Vol. 294, Iss. 4, pp. 455-481
Open Access | Times Cited: 20